Sharekhan

Gujarat Kidney and Super Speciality Ltd

Fri 22/05/2026,15:57:24 | NSE : GKSL

₹ 143.273.79 (2.72%)

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 139.80

Previous Close

₹ 139.48

Volume

736415

Mkt Cap ( Rs. Cr)

₹1129.59

High

₹ 143.83

Low

₹ 139.12

52 Week High

₹ 147.80

52 Week Low

₹ 98.36

Book Value Per Share

₹ 4.46

Dividend Yield

0.00

Face Value

₹ 2.00

What’s Your Call?

Collective community sentiment on Gujarat Kidney and Super Speciality Ltd

Your Vote -

Buy

50.00%

Hold

0.00%

Sell

50.00%

50.00%

2 users have voted

Market Depth

How many stocks are available to buy or sell and at what prices.

Buy Order Quantity

100%

Sell Order Quantity

0%

Bid Price

Qty

143.27

106

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

106

Bid Price

Qty

0.00

0

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

0

Option Chain

Analyzes market sentiment, predicts Gujarat Kidney and Super Speciality Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Guj. Kidney & Super - Board Meeting Intimation for Consideration And Approval Of Audited Quarterly And Yearly Financial Resul

    23 May 2026, 5:48PM Gujarat Kidney And Super Speciality Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/05/2026 ,inter al
  • Guj. Kidney & Super - Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2

    15 May 2026, 6:25PM <b>Format of the Annual Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border='1px'> <tr> <td><b>Sr
  • Guj. Kidney & Super - Monitoring Agency Report

    15 May 2026, 5:32PM Gujarat Kidney And Super Speciality Limited has shared Monitoring Agency Report for Quarter ended on 31.03.2026
  • Guj. Kidney & Super - Announcement under Regulation 30 (LODR)-Monitoring Agency Report

    15 May 2026, 5:20PM Monitoring Agency Report for the Quarter ended on 31.03.2026
  • Guj. Kidney & Super - General Updates

    14 May 2026, 9:16AM Gujarat Kidney And Super Speciality Limited has informed the Exchange about GKSL scales up Renal Care: 100 units AI-Powered Haemodialysis Machines to
  • Guj. Kidney & Super - GKSL Scales Up Renal Care: 100 Units AI-Powered Haemodialysis Machines To Be Inducted Across Network. F

    14 May 2026, 9:15AM GKSL Scales Up Renal Care : 100 units AI Powered Haemodialysis Machines to be inducted across network. First 8 Machines to go live at Gujarat Multi Sp
  • Guj. Kidney & Super - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A

    30 Apr 2026, 5:40PM <b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border='1px'><tr> <td><b>Sr. No.</b></td
  • Guj. Kidney & Super - General Updates

    27 Apr 2026, 10:05PM Gujarat Kidney And Super Speciality Limited has informed the Exchange about General Updates regarding approval for incorporation of wholly owned subsi
  • Guj. Kidney & Super - Appointment

    27 Apr 2026, 10:00PM Gujarat Kidney And Super Speciality Limited has informed the Exchange regarding Appointment of Mrs VISHAKHA MAHESH PHADKE as Company Secretary & Compl
  • Guj. Kidney & Super - Announcement under Regulation 30 (LODR)-Acquisition

    27 Apr 2026, 9:43PM Approval of Incorporation of Wholly Owned Subsidiary (WOS)
  • Guj. Kidney & Super - Appointment of Company Secretary and Compliance Officer

    27 Apr 2026, 9:40PM Appointment of Mrs Vishakha Mahesh Phadke as Company Secretary and Compliance Officer
  • Guj. Kidney & Super - Shareholders meeting

    25 Apr 2026, 8:03PM Gujarat Kidney And Super Speciality Limited has submitted the Exchange a copy Srutinizers report of Postal Ballot. Further, the company has informed
  • Guj. Kidney & Super - Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot

    25 Apr 2026, 7:55PM Outcome of Postal Ballot
  • Guj. Kidney & Super - Shareholder Meeting / Postal Ballot-Scrutinizer\s Report

    25 Apr 2026, 7:52PM Postal Ballot Scrutinizer's Report
  • Guj. Kidney & Super - General Updates

    20 Apr 2026, 9:57PM Gujarat Kidney And Super Speciality Limited has informed the Exchange about General Updates
  • Guj. Kidney & Super - Intimation About Payment Of Fine Levied Under Regulation 29 Of SEBI (LODR), Regulations 2015

    20 Apr 2026, 6:40PM Intimation about payment of fine levied under Regulation 29 of SEBI (LODR), Regulations 2015.
  • Guj. Kidney & Super - General Updates

    16 Apr 2026, 6:44PM Gujarat Kidney And Super Speciality Limited has informed the Exchange about intimation of receipt of Notice for non compliance with Regulation 29(2)/2
  • Guj. Kidney & Super - Intimation Of Receipt Of Notice For Non Compliance With Regulation 29(2)/29(3) Of SEBI (LODR) Regulatio

    16 Apr 2026, 6:32PM Intimation of receipt of Notice for Non compliance with Regulation 29 (2)/ 29 (3) of SEBI (LODR) Regulations, 2015
  • Guj. Kidney & Super has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2026

    7 Apr 2026, 7:00PM As of March 2026, 71.45% is owned by Indian Promoters and 28.55% by Public. <p align=justify> Top four Promoters holding highest number of shares of G
  • Guj. Kidney & Super - Certificate under SEBI (Depositories and Participants) Regulations, 2018

    7 Apr 2026, 3:57PM Gujarat Kidney And Super Speciality Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
  • Guj. Kidney & Super - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    7 Apr 2026, 3:36PM Certificate under reg 74(5) of SEBI (DP) Regulation 2011
  • Guj. Kidney & Super - Trading Window

    26 Mar 2026, 2:21PM Gujarat Kidney And Super Speciality Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Tr
  • Guj. Kidney & Super - Copy of Newspaper Publication

    26 Mar 2026, 2:18PM Gujarat Kidney And Super Speciality Limited has informed the Exchange about Copy of Newspaper Publication for postal ballot notice
  • Guj. Kidney & Super - Shareholders meeting

    25 Mar 2026, 6:15PM Gujarat Kidney And Super Speciality Limited has informed the Exchange regarding Notice of Postal Ballot
  • Guj. Kidney & Super - Outcome of Board Meeting

    25 Mar 2026, 12:26PM Gujarat Kidney And Super Speciality Limited has submitted to the Exchange, the financial results for the period ended September 30, 2025.
  • Guj. Kidney & Super - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot

    25 Mar 2026, 5:59PM Notice of Postal Ballot and e-voting
  • Guj. Kidney & Super - General Updates

    23 Mar 2026, 3:19PM Gujarat Kidney And Super Speciality Limited has informed the Exchange about General Updates
  • Guj. Kidney & Super - Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2

    23 Mar 2026, 3:10PM The company executed Parekhs Hospital Private Limited as Wholly Own Subsidiary of Gujarat Kidney and super speciality Limited on 22nd March 2026
  • Guj. Kidney & Super - Intimation Under Regulation 30 Of Securities And Exchange Board Of India (Listing Obligations And Discl

    21 Mar 2026, 2:13PM Intimation under regulation 30 of LODR, The company paid penalty imposed by BSE and NSE.
  • Guj. Kidney & Super - Change in Management

    19 Mar 2026, 9:44PM Appointment of Secretarial Auditor
  • Guj. Kidney & Super - Change in Management

    19 Mar 2026, 9:42PM Appointment of Internal Auditor
  • Guj. Kidney & Super - Announcement under Regulation 30 (LODR)-Change in Management

    19 Mar 2026, 9:18PM Appointment of Secretarial Auditor
  • Guj. Kidney & Super - Announcement under Regulation 30 (LODR)-Change in Management

    19 Mar 2026, 9:16PM Appointment of Internal Auditor
  • Guj. Kidney & Super - Outcome of Board Meeting

    19 Mar 2026, 7:28PM Gujarat Kidney And Super Speciality Limited has informed the Exchange regarding Outcome of Board Meeting held on March 19, 2026.
  • Guj. Kidney & Super - Board Meeting Outcome for Outcome For Board Meeting Outcome For Board Meeting Hold On 19Th March 2026.

    19 Mar 2026, 7:22PM In reference to the captioned subject, we hereby inform you that the Board of Directors of the Company, in their Board Meeting held on today, i.e., Th
  • Guj. Kidney & Super - General Updates

    18 Mar 2026, 2:01PM Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Intimation for receipt of Notice for
  • Guj. Kidney & Super - Reasons for Delayed/Non-submission of Financial Results

    13 Mar 2026, 1:32PM Gujarat Kidney And Super Speciality Limited has informed the Exchange about reasons for Delayed of unaudited Financial Results of September 30, 2025
  • Guj. Kidney & Super - Results-Delay in Financial Results

    13 Mar 2026, 1:19PM Disclosure of delay for Unaudited financial result for the second quarter ended on September 30,2025.\r\n\r\nThe company listed on 30th December 2025,
  • Guj. Kidney & Super - Resignation

    3 Mar 2026, 1:41PM Gujarat Kidney And Super Speciality Limited has informed the Exchange regarding Resignation of Mrs Niki Paresh Tiwari as Company Secretary & Complianc
  • Guj. Kidney & Super - Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer

    3 Mar 2026, 1:29PM Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosures Requirements) Regulation 2015, We wish to inform you that Mrs. Niki Paresh Tiwa
  • Gujarat Kidney and Super Speciality

    7 Jan 2026 , 12:27PM Gujarat Kidney And Super Speciality Limited: The board approved two major healthcare acquisitions - purchasing the remaining 49% equity stake in Harmony Medicare Private Limited for ₹107.80 crores to make it a wholly owned subsidiary, and approving ₹124 crores payment for the previously acquired Ashwini Medical Centre. Both transactions are expected to complete within two months and align with the company's healthcare sector expansion strategy.

Key fundamentals

Evaluate the intrinsic value of Gujarat Kidney and Super Speciality Ltd stock 

Name March-24 March-23
Assets 12.8359 0.3747
Liabilities 12.8359 0.3747
Equity 0.2 0.2
Gross Profit 1.5612 -0.0063
Net Profit 1.4536 -0.0062
Cash From Operating Activities -2.1104 0.0002
NPM(%) 29.19 0
Revenue 4.9797 0
Expenses 3.4185 0.0063
ROE(%) 4.13 -0.01

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to Gujarat Kidney and Super Speciality Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 705.80 -0.07 0.00 81.58 -26.19 0.71
Lotus Eye Hospital and Institute Ltd 109.19 1.26 352.23 297.28 3.55 0.00
Vaishali Pharma Ltd 7.00 0.14 0.00 1864.96 3.13 0.00
Astec Lifesciences Ltd 771.80 4.77 0.00 280.34 -363.15 0.00

Company Info

Our Company was incorporated under the name and style of `Vihaan Medicare Private Limited', a private limited company under the Companies Act, 2013, pursuant to a certificate of incorporation dated December 20, 2019 issued by the Registrar of Companies, Central Registration Centre. Subsequently, in order to align our name with the business carried out by our Company of offering multi-speciality and super-speciality medical services, pursuant to a resolution passed by our Board of Directors in their meeting held on September 04, 2023, and by our Shareholders in an extraordinary general meeting held on September 06, 2023, the name of our Company was changed to `Gujarat Kidney and Super Speciality Private Limited' and a fresh certificate of incorporation dated September 13, 2023 was issued by the Registrar of Companies, Gujarat at Ahmedabad. Further, our Company was converted into a public limited company pursuant to a resolution passed by our Board of Directors in their meeting held on November 02, 2023 and by our Shareholders in an extraordinary general meeting held on November 04, 2023 and consequently the name of our Company was changed to `Gujarat Kidney and Super Speciality Limited' and a fresh certificate of incorporation dated November 24, 2023 was issued by the Registrar of Companies, Gujarat at Ahmedabad. The corporate identification number of our Company is U85300GJ2019PLC111559.Major Events and Milestones:2014- Established and commenced operations of our first hospital under the name of `Gujarat Kidney Hospital' at Vadodara, Gujarat.2018- Shifted Gujarat Kidney Hospital to a larger premises in Vadodara, Gujarat to expand the bed capacity from fifteen (15) to sixty five (65).- Established five sub-specialities in our uro department, viz., endourology, urologic oncology, paediatric urology, reconstructive urology, and laparoscopic urology at our Gujarat Kidney Hospital.2019- Set up an in-house interventional cardiology department under the name of `Gujarat Heart Care Unit' for offering invasive cardiology services2021- Successfully carried out our first laparoscopic radical prostatectomy at our Gujarat Kidney Hospital2023- Established and commenced operations of our second hospital in Godhra, Gujarat.- Successfully carried out our first renal transplant at our Gujarat Kidney Hospital.- Successfully carried out our first Angiography at our Godhra Hospital.- Established three in-house super-speciality departments for cardiology, urology and nephrology at our Godhra Hospital.2024- Successfully carried out our first retrograde intrarenal surgery ("RIRS") at our Godhra Hospital.- Acquired majority stake in Raj Palmland Hospital Private Limited, thereby making it our Subsidiary- Acquired our Gujarat Kidney Hospital.- Acquired our Godhra Hospital.- Acquired controlling interest of 90% in M/s Surya Hospital and ICU.- Acquired controlling interest of 90% in M/s. Gujarat Surgical Hospital.2025- Acquired Ashwini Medical Centre.- Acquired Ashwini Medical Store- Acquired 51% of equity shares of Harmony Medicare Private Limited

Our Company was incorporated under the name and style of `Vihaan Medicare Private Limited', a private limited company under the Companies Act, 2013, pursuant to a certificate of incorporation dated December 20, 2019 issued by the Registrar of Companies, Central Registration Centre. Subsequently, in order to align our name with the business carried out by our Company of offering multi-speciality and super-speciality medical services, pursuant to a resolution passed by our Board of Directors in their meeting held on September 04, 2023, and by our Shareholders in an extraordinary general meeting held on September 06, 2023, the name of our Company was changed to `Gujarat Kidney and Super Speciality Private Limited' and a fresh certificate of incorporation dated September 13, 2023 was issued by the Registrar of Companies, Gujarat at Ahmedabad. Further, our Company was converted into a public limited company pursuant to a resolution passed by our Board of Directors in their meeting held on November 02, 2023 and by our Shareholders in an extraordinary general meeting held on November 04, 2023 and consequently the name of our Company was changed to `Gujarat Kidney and Super Speciality Limited' and a fresh certificate of incorporation dated November 24, 2023 was issued by the Registrar of Companies, Gujarat at Ahmedabad. The corporate identification number of our Company is U85300GJ2019PLC111559.Major Events and Milestones:2014- Established and commenced operations of our first hospital under the name of `Gujarat Kidney Hospital' at Vadodara, Gujarat.2018- Shifted Gujarat Kidney Hospital to a larger premises in Vadodara, Gujarat to expand the bed capacity from fifteen (15) to sixty five (65).- Established five sub-specialities in our uro department, viz., endourology, urologic oncology, paediatric urology, reconstructive urology, and laparoscopic urology at our Gujarat Kidney Hospital.2019- Set up an in-house interventional cardiology department under the name of `Gujarat Heart Care Unit' for offering invasive cardiology services2021- Successfully carried out our first laparoscopic radical prostatectomy at our Gujarat Kidney Hospital2023- Established and commenced operations of our second hospital in Godhra, Gujarat.- Successfully carried out our first renal transplant at our Gujarat Kidney Hospital.- Successfully carried out our first Angiography at our Godhra Hospital.- Established three in-house super-speciality departments for cardiology, urology and nephrology at our Godhra Hospital.2024- Successfully carried out our first retrograde intrarenal surgery ("RIRS") at our Godhra Hospital.- Acquired majority stake in Raj Palmland Hospital Private Limited, thereby making it our Subsidiary- Acquired our Gujarat Kidney Hospital.- Acquired our Godhra Hospital.- Acquired controlling interest of 90% in M/s Surya Hospital and ICU.- Acquired controlling interest of 90% in M/s. Gujarat Surgical Hospital.2025- Acquired Ashwini Medical Centre.- Acquired Ashwini Medical Store- Acquired 51% of equity shares of Harmony Medicare Private Limited

Parent Organisation

Gujarat Kidney and Super Speciality Ltd.

Founded

20/12/2019

Managing Director

Dr.Pragnesh Yashwantsinh Bharpoda

NSE Symbol

GKSLEQ

FAQ

OPEN FREE* DEMAT ACCOUNT